New resolution of 2-formyl-1,4-DHP derivatives using CIDR methodology. Facile access to new chiral tricyclic thiolactam

Journal of Organic Chemistry

Volumn 69, Issue 12, 2004, Pages 4227-4237

  Marchalín, Štefan ^a   Cvopová, Katarína ^a   Križ, Miroslav ^b   Baran, Peter ^c   Oulyadi, Hassan ^d   Daïch, Adam ^e  

^a SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^b Physics and Informatics   (Slovakia)

^c UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^d UNIVERSITÉ DE ROUEN   (France)

^e UNIVERSITÉ DU HAVRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADDITION REACTIONS; CRYSTALLIZATION; DERIVATIVES; HYDROLYSIS; SOLUBILITY; SOLUTIONS;

CYCLOADDITION;

ALDEHYDES;

2 FORMYL 1,4 DIHYDROPYRIDINE DERIVATIVE; ALDEHYDE; ALPHA METHYLBENZYLAMINE; DIHYDROPYRIDINE DERIVATIVE; HYDROCHLORIC ACID; IMINE; LACTAM DERIVATIVE; MERCAPTAMINE; SCHIFF BASE; THIAZOLE; THIOL; THIOLACTAM; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL ANALYSIS; CHIRALITY; CRYSTALLIZATION; CYCLOADDITION; DYNAMICS; HYDROLYSIS; POLYMERIZATION; PRECIPITATION; SOLUBILITY; STEREOISOMERISM; X RAY DIFFRACTION;

CALCIUM CHANNEL BLOCKERS; CRYSTALLIZATION; DIHYDROPYRIDINES; LACTAMS; MODELS, MOLECULAR; STEREOISOMERISM;

EID: 2942560555     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo049706s     Document Type: Article

References (63)

1. For reviews, see: (a) Bossert, F.; Vater, W. Med. Res. Rev. 1989, 9, 291.
2. (b) Goldmann, S.; Stoltefuss, J. Angew. Chem. Int. Ed. Engl. 1991, 30, 1559 and references therein.
3. (c) Marchalín, Š.; Chudík, M.; Mastihuba, V.; Decroix, B. Heterocycles 1998, 48, 1943 and references therein.
4. Chudík, M.; Marchalín, Š.; Daïch, A.; Decroix, B. Res. Adv. Synth. Org. Chem. 2000, 1, 1.
5. (a) Sobolev, A.; Franssen, M. C. R.; Vigante, B.; Cekavicus, B.; Makarova, N.; Duburs, G.; de Groot, A. Tetrahedron: Asymmetry 2001, 12, 3251.
6. (b) Sobolev, A.; Franssen, M. C. R.; Vigante, B.; Cekavicus, B.; Zhalubovskis, R.; Kooijman, H.; Spek, A. L.; Duburs, G.; de Groot, A. J. Org. Chem. 2002, 67, 401 and references therein.
7. (a) Vo, D.; Matowe, W. C.; Ramesh, M.; Iqbal, N.; Wolowyk, M. W.; Howlett, S. E.; Knaus, E. E. J. Med. Chem. 1995, 38, 2851.
8. (b) Shan, R.; Howlett, S. E.; Knaus, E. E. J. Med. Chem. 2002, 45, 955.
9. Kosugi, Y.; Hori, M.; Nagasaka, T. Heterocycles 1994, 39, 591.
10. (a) Iqbal, N.; Vo, D.; McEwen, C. A.; Wolowyk, M. W.; Knaus, E. E. Chirality 1994, 6, 515.
11. (b) Peri, R.; Padmanabhan, S.; Rutledge, A.; Singh, S.; Triggle, D. J. J. Med. Chem. 2000, 43, 2906.
12. (a) Holdgrüm, X. K.; Sih, C. J. Tetrahedron Lett. 1991, 32, 3465.
13. (b) Ebiike, H.; Terao, Y.; Achiwa, K. Tetrahedron Lett. 1991, 32, 5805.
14. (c) Ebiike, H.; Maruyama, K.; Achiwa, K. Tetrahedron: Asymmetry 1992, 3, 1153.
15. Chudík, M.; Marchalín, Š.; Knesl, P.; Daïch, A.; Decroix, B. J. Heterocycl. Chem. 2000, 37, 1549.
16. (a) Chudík, M.; Marchalín, Š.; Havrilová, K. Collect. Czech. Chem. Commun. 1998, 63, 826.
17. (b) Chudík, M.; Marchalín, Š.; Pham-Huu, D.-P., Humpa, O.; Friedl, Z. Monatsh. Chem. 1999, 130, 1241.
18. (c) Marchalín, Š.; Cvopová, K.; Pham-Huu, D.-P.; Chudík, M.; Kožíšek, J.; Svoboda, I.; Daïch, A. Tetrahedron Lett. 2001, 42, 5663.
19. Marchalín, Š.; Chudík, M.; Cvopová, K.; Kožíšek, J.; Leško, J.; Daïch, A. Tetrahedron 2002, 58, 5747.
20. (a) Satoh, Y.; Ichihashi, M.; Okumura, K. Chem. Pharm. Bull. 1991, 39, 3189.
21. (b) Satoh, Y.; Okumura, K.; Shiokawa, Y. Chem. Pharm. Bull. 1992, 40, 1799.
22. For use of the popular α-phenylethylamine (α-PEA) as the chiral resolving agent, see: Juaristi, E.; Escalante, J.; Léon-Romo, J. L.; Reyes, A. Tetrahedron: Asymmetry 1998, 9, 715.
23. The starting material, 1,4-DHP derivative 4, could be obtained in large scale-up to 20 g in a single preparative step.
24. (a) For recent review related to this subject, see: Caddick, S.; Jenkins, K. Chem. Soc. Rev. 1996, 25, 447 and references therein.
25. (b) For recent examples, see:
26. (c) Boesten, W. H. J.; Seerden, J.-P. G.; De Lange, B.; Dielemans, H. J. A.; Elsenberg, H. L. M.; Kaptein, B.; Moody, H. M.; Kellogg, R. M.; Broxterman, Q. B. Org. Lett. 2001, 3, 1121.
27. (d) Košmrlj, J.; Weigel, L. O.; Evans, D. A.; Downey, C. W.; Wu, J. J. Am. Chem. Soc. 2003, 125, 3208.
28. The proximity of a chiral auxiliary to the labile stereocenter in the crystallization process is sometimes no as important. See ref bellow 14.
29. See the Supporting Information for the ORTEP drawing of the enantiopures imines (4S,1′R)-6 and (4S,1′R)-6.
30. For representative references, see: (a) Vernin, G.; Metzger, J. Bull. Soc. Chem. Belg. 1981, 30, 553.
31. (b) Fernandez, X.; Fellous, R.; Duñach, E. Tetrahedron Lett. 2000, 41, 3381.
32. (a) For the X-ray single-crystal structure determination of (4S,2′R,4′R)-9, see the crystallographic characteristics in the Supporting Information (SI1).
33. (b) See also: Vrábel, V.; Kožíšek, J.; Marchalín, Š. Acta Crystallogr. 2003, E59, 1064.
34. (a) For similar results, see the following review: Ebbes, E. J.; Ariaans, G. J. A.; Houbiers, J. P. M.; Bruggink, A.; Zwanenburg, B. A. Tetrahedron 1997, 53, 9417 and references therein.
35. (b) Napolitano, E.; Farina, V. Tetrahedron Lett. 2001, 42, 3231.
36. Eliel, E. L.; Wilen, S. H.; Mander, L. N. Stereochemistry of Organic Compounds; John Wiley & Sons: New York, 1994; pp 364-665.
37. Pesek, J. J.; Frost, J. H. Tetrahedron 1975, 31, 907.
38. Nagasawa, H. T.; Goon, D. J. W.; Shirota, F. M. J. Heterocycl. Chem. 1981, 18, 1047.
39. Hamri, A.; Péra, M.-H.; Fillion, H. J. Heterocycl. Chem. 1987, 24, 1629.
40. For example of spectroscopic study on 1,3-thiazoles, see: Fülöp, F.; Mattinen, J.; Pihlaja, K. Tetrahedron 1990, 46, 6545 and references therein.
41. (a) Caddick, S.; Jenkins, K. Tetrahedron Lett. 1996, 37, 1301.
42. (b) Kubo, A.; Kubota, H.; Takahashi, M.; Nunami, K. I. J. Org. Chem. 1997, 62, 5830.
43. (c) O'Meara, J. A.; Gardee, N.; Jung, M.; Ben, R. N.; Durst, T. J. Org. Chem. 1998, 63, 3117.
44. (d) Ben, R. N.; Durst, T. J. Org. Chem. 1999, 64, 7700.
45. (e) Lee, S.-K.; Lee, S. Y.; Park, Y. S. Synlett 2001, 1941.
46. Shieh, W.-C.; Carlson, J. A.; Zaunius, G. M. J. Org. Chem. 1997, 62, 8217.
47. Cimarelli, C.; Mazzanti, A.; Palmieri, G.; Volpini, E. J. Org. Chem. 2001, 66, 4759.
48. Okada, Y.; Takebayashi, T.; Hashimoto, M.; Kasuga, S.; Sato, S.; Tamura, C. J. Chem. Soc., Chem. Commun. 1983, 784.
49. Kolarovic, A.; Berkes, D.; Baran, P.; Povazanec, F. Tetrahedron Lett. 2001, 42, 2579.
50. For the X-ray single-crystal structure determination of (4S,2′S,4′R)-15, see the crystallographic characteristics in the Supporting Information.
51. For the stereochemical study of optically active thiazolidines, see: Cruz, A.; Vásquez-Badillo, A.; Ramos-García, I.; Contraras, R. Tetrahedron: Asymmetry 2001, 12, 711.
52. The oxygenated heterologues of these tricyclic lactams were elegantly and fully exploited by numerous groups, notably by Meyers. For more information, see the following reviews: (a) Romo, D.; Meyers, A. I. Tetrahedron 1991, 47, 9503.
53. (b) Groaning, M. D.; Meyers, A. I. Tetrahedron 2000, 54, 9843.
54. For the X-ray single-crystal structure determination of (±)-(6R,-9bR)-21, see the crystallographic characteristics in the Supporting Information.
55. For the X-ray single-crystal structure determination of (4R,2′S)-20, see the crystallographic characteristics in the Supporting Information.
56. Cooper, J.; Humber, D. C.; Long, A. G. Synth. Commun. 1986, 16, 1469.
57. Tremmel, P.; Brand, J.; Knapp, V.; Geyer, A. Eur. J. Org. Chem. 2003, 878.
58. (a) Mertens, A.; Zilch, H.; Koenig, B.; Schaefer, W.; Poll, T.; Kampe, W.; Seidel, H.; Leser, U.; Leinert, H. J. Med. Chem. 1993, 36, 2526.
59. (b) Jingshan, R.; Esnouf, R. M.; Hopkins, A. L.; Stuart, D. I.; Stammers, D. K. J. Med. Chem. 1999, 42, 3845.
60. Substitution of the phenyl ring of cephalexin with certain substituents does not appear to modify significantly the antibacterial properties of cephalexin (R = H). For more information, see: Ryan, C. W.; Simon, R. L.; Van Heyningen, E. M. J. Med. Chem. 1969, 12, 310.
61. (a) Elhkorn, F. A.; Guo, T.; Lipton, M. A.; Goldberg, S. D.; Bartlett, P. A. J. Am. Chem. Soc. 1994, 116, 10412.
62. (b) Wagner, J.; Kallen, J.; Ehrhardt, C.; Evenou, J.-P.; Wagner, D. J. Med. Chem. 1998, 41, 3664.
63. Yoshinari, S.; Japanese Patent. FR 2,315,930, 1977; US 4,145,432, 1977; Chem. Abstr. 1977, 86, 189726.